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Abstract 
Introduction: The identification of relevant components of successful weight reduction 
sUIgery is the most important endeavor in the latest research aiming to increase excess 
weight loss. Over the past twenty years there has been ongoing discussion about the 
importance of gastric pouch size as one of the key factors influencing weight loss after 
restrictive weight reduction surgery. The goal of our analysis is to determine the relationship 
between gastric pouch size and weight reduction following laparoscopic Roux-Y gastric 
bypass (LRYGB). 
Methods: Between August 2002 and March 2005, 321 LRYGB procedures were performed 
at the same institution. Patient demographics were entered into a longitudinal, prospective 
database. Upper gastrointestinal series were performed in all patients on postoperative day 
one. Assuming that pouch depth remained constant, pouch size was calculated as area (cm~ 
utilizing digital imaging technology and internal standardization for measurement. Linear 
regression analysis was performed to determine the association between pouch size and 
weight loss at 6 and 12 months postoperatively. Adjustment was made for age, gender, and 
preoperative BMI. 
Results: Mean age was 41 years (range, 17-64); 262 patients were female (81.6%); mean 
preoperative BMI was 51.1 kg/m2 (range, 36.1-89.9 kg/m1. Mean 6 month %EWL was 50.5 
(range, 13.4-85.5%) and mean 12 month %EWL was 62.5 (range, 14.6-98.1). Mean pouch 
size was 63.9 cm2 (range, 8.6-248.0 cm~ . A statistically significant inverse correlation 
between pouch size and %EWL was found at 6 months (~ = -0.241, p<O.Ol) and at 12 
months ~ = -0.302, p<O.02). A significant correlation was found between pouch size, male 
gender and preoperative BMI but not between pouch size and age. 
Conclusion: Our analysis demonstrates that gastric pouch size is one important component 
for successful weight reduction following LRYGB. The creation of a small gastric pouch 
should be encouraged as the initial step towards ideal weight loss. 
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Introduction 
With the prevalence of morbid obesity ever increasing and few if any successful 
alternatives, patients are seeking out bariatric surgery as definitive treatment in record 
nwnbers. With the decreased associated morbidity and mortality, laparoscopic Roux-
Y gastric bypass (LRYGB) has emerged as the procedure of choice for those electing 
surgery. Since all patients must first demonstrate failed non-surgical regimens, 
LRYGB frequently provides a last resort. Consequently, it is imperative that the 
factors contributing to a successful outcome be elucidated. Over the past twenty 
years, debate has ensued about the import of gastric pouch size as one of these 
factors, yet a paucity of literature exists substantiating the association between gastric 
pouch size and weight loss following gasttic bypass surgery. 
The goal of this analysis is to determine the relationship between the surgically 
created gastric pouch and e..'{cess weight loss specifically after laparoscopic Rou.'{-Y 
gastric bypass, as well as to identify any factors possibly confounding thls association. 
We hypothesized that there is a significant inverse relationship between pouch size 
and resultant excess weight loss, ie. the smaller the pouch the greater the weight loss. 
8 
Background: 
Obesity is not a new phenomenon. Neither are the societal stigma and prejudice 
associated with it. Perhaps most interestingly, the surgical treatment for obesity is not 
novel to the 20th century. Claudius Aelian (170-235 A.D.) in his treatise on Ancient 
Greece, Hiltoncal Misceiia,!}. wrote of a man of gluttony too ashamed to leave his 
house because of his extreme corpulence and the physicians who attempted a surgical 
remedy for his affliction while he was sleeping. [1] Though we do not know the 
particulars of the procedure, nor its outcome, we are left with a treatment p.recedent 
for taday's epidemic of obesity. Using the standard measurement of body mass index 
(BMI) in kilograms/ meters2, which has been shown to accurately reflect body fat 
stores, a BMI 2' 25 kg/m2 is overweight and 2' 30 kg/m2 is obese. A BMI of 40 
kg/m2 roughly reflects 100 Ibs of overweight for an average adult male. [2] Once a 
disease associated with excess means, privilege, and social status, in the past 50 years 
there has been a greater rise in the rates of obesity amongst those who are poor, 
minorities and underprivileged.[3] Roughly 55% of Americans are now considered 
obese, with a BMI 2' 30 kg/mo. 
Though the rates of obesity remained steady in the first two-thirds of the twentieth 
century, between 1970 and 2000, the number of obese Americans nearly doubled. 
(Figure 1) 
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Figure 1. Obes ity Trends By Gender 1960-2000. 
While there are many elaborate theories offered as explanation for the cause of this 
phenomenon, one argument that persists is that the rates of physical labour have 
decreased, wages have increased, and the price of calorie dense foods have decreased 
relative to natural and complex carbohydrate alternatives. While the answer to this 
question remams elusive, one thing is for certain: the rise in obesity reflects an 
increase in caloric consumption with a decrease in energy expenditure. Finkelstein et 
aI. writes that this trend in obesity over the past 50 years can be explained simply by 
an increase in the American diet of 50-100 calories per day. [4] 
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The implications of obesity transcend mete cosmetics, as it is a major cause of 
comorbidities, including. type two diabetes, cardiovascular disease, stroke, 
hypertension, hyperlipidemia, gallbladder disease, sleep apnea, Pickwickian syndrome, 
arthropathies, uterine, prostate and breast cancers and infertility, among others. [5-8] 
The risk of these comorbid conditions rises directly with an increase in BMI. and 
both morbidity and mortality are proportional to degree of overweight [9], as 
depicted in Figure 2. Furthennore, higher BMI. and obesity specifically, is associated 
with an increase in all cause mortality. [9] In 2002, 400,000 U.S. deaths were 
attributed to obesity related causes, making it the second most common cause of 
death from a modifiable behavior, lagging only behind smoking. [10] With 53 million 
obese, adult Americans, and 17.5 million obese or overweight children and without 
any evidence of the epidemic plateauing or approaching a downward trend [11] the 
cost to the health care system is astronomical, Though reports vary slightly, most 
agree that as of 2003, ,.... 7-9 % of total annual medical expenditures or between $70 
and $95 billion dollars are spent on obesity related diseases, approximately half of 
which are paid for by Medicare and Medicaid. [12, 13] 
II 
Increased Risk of Obesity Related Diseases 
, with Higher BMI 
Disease BMlof 8MI between 8MI between 8Mlof 
250'" less 25and 30 30 and 35 35 or more 
Arthritis 1.00 1.56 1.B7 2.39 
Heart Disease 1.00 1.39 1.86 1.67 
Diabetes (Type 1.00 2.42 3.35 6,16 
2) 
Gallstones 1.00 1.97 3.30 5 .48 
Hypertension 1.00 1.92 2.82 3.77 
Stroke 1.00 1.53 1.59 1.75 
[14] 
Figure 2. Risk of Comorbid Conditions with Increasing 8MJ. 
Figure 3 shows the direct cost of obesity related co-morbidities and their percentage 
of total disease direct cost Sturm et al. in his analysis of the economic consequences 
of obesity, found that obese adults have 36% higher average annual medical costs 
than those adults of normal weight. [1 5] Furthering the economic impact of obesity, 
Colclirz reports that obese workers take more sick leave and are on more disability 
due to weight related problems than do their normal weight counterparts; potentially 
10% of sick leave and disability pensions in women may be attributed to obesity and 
its associated conditions. [16] In Sweden, obese workers were found between 1.5 to 
1.9 times more likely to take sick leave than their noanal weight counterparts, and 
12% o f women had disability pensions attributable to obesity, at a cost of $300 
million for 1 million women in the adult population. [1 7] Wolf confirmed similar 
findings for the U.S. work force, "in 1994, there were 263 million restricted activity 
days and 58.4 million work days lost among those with BMl >27 kg/m2. when 
12 
compared to nonobese individuals. Annually, lost productivity amounts to $5.7 
billion dollars." [18] 
For men, even moderate obesity is associated with a 50% increase in the probability 
of limiting activities of daily living (ADLs), a figure that rises to 300% with severe 
obesity. These estimates are even more severe for women, as this probability of ADL 
limitation doubles with moderate and quadruples with severe obesity. [15] 
I· .: Obesjty Costs In Rei<ltion to the Co,.Morbia~ies /t 
~; '"', . .. .J . (19~9 dollars In billions) "'''. ", 
'! Disease . Direct Cost Of ; Dir~cl Cost of 1 Direct Cost of'ObeSity as . , .Obesity, Dj~se I " % of Total lDirect Cost 
Arthritis 57.4 $23.1 32" 
Breast Cancer $2.t $10.2 21" 
Heart Disease $30.6 $101.8 30" 
Colorectal Cancer $2.0 $10.0 20" 
Diabetes (Type 2) $20.5 $47.2 .,,, 
Endometrial Cancer $0.6 $2.5 24" 
ESRD $3.0 $14.9 20% 
Gallstones $3.5 $7.7 45" 
Hypertension $9.6 $24.5 3"" 
Liver Disease $3.4 $9.7 35" 
LoW Back Pain $3.5 $19.2 18" 
Renal Cell Cancer $0.5 $1.6 31" 
Obstructive Steep $0.2 $0.4 50% 
Apnea 
stroke $8.1 "$29.5 27" 
Urinarylncontinenoe $7.6 529.2 26" 
. Total Direct Cost $102.2 $331 .4 31" 
[19] 
Figure 3. Cost of Obesity Related Comorbidities. 
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Seeking to remedy or at least abate the health implications of obesity, in 1991, the 
National Institutes of Health convened a consensus panel on the surgical treatment 
of obesity. Although not the first panel held of this sort, either by this institution or 
by others, the panel delineated a set of guidelines that are still in practice today. 
Recorrunendations include that obese patients should first undergo medically 
supervised efforts at calorie restricting diets, with a goal of 10% weight reduction per 
year through a combination of caloric restriction and behaviour therapy. [9] 
However, in the intervening time, studies examining the effects of calorie restriction 
are not encouraging for those suffering with obesity. Very low calorie cUets (600-800 
cal/ day) have been shown to reduce weight by only 4% over 3-5 years (Figure 4), well 
less than the recommended reduction of 10% per year. [20] Furthennore, recidivism 





-0.5 o 1 2 3 4 5 
Years After Treatment 
[21] 
Figure 4. Outcome of Very Low Calorie Diets Over Time. 
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Perhaps more surprisingly, exercise also has not been shown to promme and induce 
weight loss in this population [2, 22], but it has been shown to improve 
cardiovascular health. which is otherwise compromised by the state of obesity and is 
therefore recommended by the panel. Overweight and obese panents should be 
advised to begin regular exercise six out of seven days per week. 
Efforts at pharmacological intervention have also been put forth as potential therapy 
for obesity, but with limited success and sometimes dire consequences. At the time 
of the 1996 NIH consensus, drugs recommended for the treatment of obesity 
included phentennine hydrochloride. fenfluramine hydrochloride, fenlafexine 
hydrochloride (fen-phen) and sibutramine. The former were ultimately taken off the 
market because of their implication in severe valvulopathies. [23J Interestingly, in 
1994, the year that fen-phen prescriptions went from 50,000 to 1 million per year, 
theJ:e was a corresponding decrease in the number of bariatric procedures, but in the 
year those drugs were taken off the market (1997), there was a sharp increase in the 
number of bariatric surgeries performed. [24] Sibutramine, a noradrenergic and 
serotonin reuptake inhibitor, remains on the market although it has not been shown 
to significantly impact long term weight loss and is contraindicated in patients with 
hypertension or a history of coronary artery disease, congestive heart failure, 
arrhytlunias or stroke. [25] Finally, since the 1997 consensus report, orlistat,[26] 
which blocks absorption of dietary fat by inhibiting the activity of pancreatic lipase 
[27] has been approved for weight loss though it too has many side effects and has 
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not yet been shown to significantly lower excess body weight. Figure 5 shows the 
long-tenn efficacy of the three common weight loss drugs as compared with placebo. 
'Lon~-term Effectiv,eness of Weight Loss o,rugs: 





Weight loss above 




Weight los above 





Figure 5. Comparisol1 or Popula r Weight Loss Drugs. 
Finaliy, with respect to phannacotherapy for obesity, many are skeptical about 
prescribing additional medications to patients who frequently are alteady on 
complicated pharmaceutical regimens for comoIbid conditions out of concern for 
inducing noncompliance. [26] 
The only option put forth by the 1991 consensus panel that repeatedly has been 
proven to impact long tenn weight loss, is surgery; and in 1996, the NIH panel 
maintained that surgery .remains "the only effective therapy for morbid obesity." [28] 
An earlie.r consensus panel, convened in 1978, had initially conferred on and 
approved jejunoileal bypass surgery for the treatment of obesity. [29] However, by 
1991, when the panel reconvened, experience had shown that this su.rgery was 
dangerous, resulting in severe electrolyte and nutritional deficiencies. In the 
16 
intervening time, however, numerous other surgical procedures emerged, which have 
proven both safer and equally efficacious as the original one recommended. Edward 
Mason wrote that the ideal bariatric operation should limit the ability to overeat and 
yet allow nonna! nutrition. [30] MacLean echoed Mason's sentiment, noting that the 
"ideal operation for obesity should rely on manipulation of satiety rather than the 
production of malabsorption." [31] All of the surgical procedures for weight loss 
involve the creation of an effective gastric pouch, smaller than the nonnal anatomic 
stomach. Theorists posit that passive stretch of the stomach following ingestion of 
food stimulates satiety, probably via afferent vagal signaling. However, even the 
earliest bariatric surgeons recognized the loophole in this theory, noting: ''Even with 
the pouch left after 75% gastrectomy, the determined glutton can maintain his 
weight." [32] Patients can undermine the success of the procedure by consuming 
high calorie liquids, alcohol or not ceasing to eat once they have reached satiety. 
Today, there are four basic classes of bariatric surgery: Malabsotptive: including 
jejunoileal bypass, biliopancreatic diversion and duodenal switch. 
Malabsorptive/Restrictive: including Roux-Y gastric bypass (both short and long 
limb). Restrictive: including gastric banding (ringed, vertical, and horizontal 
gastroplasty). A fourth group: Experimental, includes gastric pacing, which is in 
phase 3 trials. The four most conunonly performed procedures are depicted in 
Figure 6. 
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Figure 6. The Four Common Bariatric Surgical Procedures. 
Printed with permission; copyright 10 2002 American Medical Association. All Rights reserved. [33] 
Regardless of the specific procedure, several guiding principles have emerged 
regarding bariatric surgery in and of itsdf: 
1. low risk of mortality « 1 %) 
2. low risk of morbidity « 10%) 
3. long tem! reduction of excess body weight ( > 50% EWL in at least 75% pts) 
4. low rate of reoperation 
18 
5. reversible and reproducible 
6. result in an improved quality of life. [10,34,35] 
While an in-depth description of each of the bariatric procedures is beyond the scope 
of this paper, some discussion is necessary to help elucidate why laparoscopic Roux-
Y gastric bypass has emerged as the "gold standard" and the procedure of choice in 
the Unites States. In the 19505, jejunoileal bypass was being performed as a 
malabsorptivel maldigestive procedure for morbid obesity. The operation 
functionally limited the small intestine length and surface area, which resulted in 
decreased digestion and decreased subsequent absorption of digested elements. 
However, complication rates were incredibly high: gas-bloat syndrome, steatorrhea, 
electrolyte imbalance. nephrolithiasis, hepatic fibrosis and impaired mentation [36] 
were more the nonn than the exception. Cirrhosis was the most serious 
complication, conjectured to be due to the absorption of bacterial overgtowth 
degradation products. The absorption of these products also caused rheumatoid 
arthritis due to antigen (the degraded bacterial byproducts)-antibody complexes, 
which were found to be deposited in joint spaces [37]. Ultimately, the jejunoileal 
bypass was abandoned and should not be used in practice today. 
Restrictive procedures, typified by hparoscopic adjustable gastric banding and vertical 
banded gastroplasty, rely on the construction of a small gastric pouch with a 
restricted outlet along the lesser curvature of the stomach. [29J Many patients opt for 
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a banding procedure because it has the lowest long-term complication rate [37J and 
does not alter nonnal anatomy. [38] It is worthwhile to note that outside the United 
States, and in Europe and Australia in particular, gastric banding procedures are the 
most frequent surgical procedures for obesity.[38] Sugennan found that severe 
gastric reflux, which can develop after vertical banded gastroplasty, resolves after 
patients undergo conversion to gastric bypass. He also credits gastric bypass with 
being more efficacious than vertical banded gastIoplasty in normalizing glucose 
tolerance in those patients without over non-insulin dependent diabetes mellitus. [37, 
39J 
Weight loss after banding, however, remains marginal. Proximal pouch dilation is the 
most frequent cause of post-operative complication,[40] which some argue is the 
cause of the inferior weight loss. Biliopancreatic diversion, which entails gastric 
restriction and diverts bile and pancreatic fluids into the distal ileum [22] results in the 
most drastic weight loss, but complications and nutritional deficiencies ate more 
commonly the rule than the exception thereby deviating sharply from the above 
stated preeminent guideline for bariatric surgery, i.e. low morbidity and mortality. 
In one of the longest prospective studies companng long-term outcomes after 
obesity surgery, Sjostrom published the resultant weight loss after each of the three 
common procedures as compared with conventional, non-surgical treatment of 
obesity. His findings are depicted in Figure 7. As have many other authors, 
20 
Sjostrom confirmed gastric bypass as the most successful procedure with respect to 
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Figure 7. Weight Loss Following The Three Common Bariatric Procedures. 
Printed with permission; copyright 0 2004 NElM. All Rights reserved. (41] 
Regardless of the specific type, bariatric surgery has demonstrated significant 
acWevements with respect to reducing the health impact of obesity. In the Swedish 
Obesity Study, Sjostrom showed that those treated with surgery as compared with 
conventional medical therapy had higher two and ten year rates of recovery from 
diabetes, hypertriglyceridemia, low levels of high-density lipoprotein cholesterol, 
hypertension, and hyperuricemia. [41] Buchwald goes so far as to declare that the 
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surgical treatment of obesity ameliorates the medical, social, econorruc, comorbid 
conditions of morbid obesity, and is cast effective. [111 Larsen et al demonstrated 
that poor self-confidence, neuroticism and depression, frequently concomitant with 
the state of obesity, virtually disappear after bariatric surgery. [42] 
Patient Eligibility for Surgety 
As surgical techniques have evolved over recent years, those who are candidates for 
bariatric surgery have also increased. Once, it was considered those with super~ 
obesity (EM! 2: 50 kg/m') or super-super obesity (EM! 2: 60 kg/m'), those older 
than 60 or adolescents, were ineligible due to technical constraints and operative risk. 
However, with more sophisticated screening procedures, and safer operative 
techniques, bariatric procedures have been performed successfully on these once 
ineligible patients.[43] In general, however, selection criteria initially elucidated by 
the NIH consensus panel and augmented by surgeons, remain fairly consistent: 
1. Patients with BMI ~ 40 kg/m2 or ~ 35 kg/m2 with comorbid conditions. 
2. D ocumented failed previous attempts at conventional and/or medical therapy. 
3. Motivated patients who are cooperative with pre-operative counseling and 
educational efforts. 
4. Understanding of the procedure's risks and benefits. 
5. Be amenable and ready to undergo lifelong follow up and medical supervision. 
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Accept an ce of Bariatric Surgery 
Bariatric surgery has evolved from what it once was and the evolution is most evident 
by its growing popularity. In 1994, only 22% of internists admitted to knowing about 
bariatric surgery, 7% of internists knew of patients treated with surgery, 3% had read 
about it, none would recommend it or refer a patient, and 18% would advise against 
it. [44J Yet by 1996, when Edward Mason surveyed 151 chainnen of academic 
surgical departments, 71 % acknowledged that the surgery was safe and 77% thought 
it should be used for the treatment of obesity. [45J Berween 1998 and 2002, the 
number of bariatric procedures increased from 12,774 to 70,774 or an increase of 
6.4% to 37.7% procedures pet 100,000 [46J and the number of surgeons in the 
American Society of Bariatric Surgeons increased from 258 to 631. (Figure 8) 
Number of ASBS Bariatric Surgeons YS Year 
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California alone demonstrated a 4115% increase in the number of weight restrictive 
procedures in that same four year period, indicating that bariatric surgery is on the 
rise and is becoming mainstream. It is estimated that 140,000 bariatric procedures 
will be perfonned in the United States in 2005. [47] The brisk rise in the number of 
bariatric procedures (Figuxe 9) parallels the dissemination of and competence with 
laparoscopic procedures. Cottam and Nguyen liken the frequency to the rise in 
antire flux procedures between 1991 and 1996 after the introduction and widesp.read 
utilization oflaparoscopy. [47,48] 
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Figure 9. Rise of Bariatric Procedures J990-2002. 
[46] 
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Still, only 1 in 600 morbidly obese patients have undergone gastric bypass, 
"suggesting poor acceptance of open gastric bypass by patients and physicians with 
regard to perioperacive outcomes." [47] Unfortunately, with the rates of obesity as 
they are presently, surgical therapy has not, nor shows any signs of, making dent in 
the epidemic from a community health standpoint [38] even despite studies showing 
that weight loss is greater after and the cost of surgery is exceeded within five years of 
conventional medical therapy. [l1J Nevertheless, with the gain in life expectancy, 
improved overall health and psychosocial condition, plus the greater employment 
opportunities that surgery affords, surgical therapy for the treatment of obesity will 
continue to become more popular and more mainstream in the absence of any other 
viable alternatives. 
Rationale for Laparoscopy 
Because the procedures are similar between laparoscopic and open, one would expect 
that outcomes should be similar between the two. And in fact, studies comparing 
estimates of excess weight loss axe comparable between the two techniques, given 
sufficient follow-up. Comparing long term weight loss between laparoscopic and 
open gastric bypass, studies demonstrate a higher percentage of excess weight loss 
after laparoscopically performed gastric bypass at six months, a difference that 
disappears by one and three years after surgery. [47, 49, 50) Nguyen posits this early 
result is due to faster resumption of physical activity and initiation of exercise 
programs in the laparoscopic group. [47] 
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However, when analyzing the two different approaches other factors besides weight 
loss come into play. Although open gastric bypass can be performed safely with low 
morbidity and mortality, wound complications, including infections and incisional 
hernias are still formidable risks. Kellum et al quote these complications are as high 
as 15% and 20%, respectively. [51] There is still much debate about the degree of 
post-operative pain associated with the two procedures - Nguyen [47, 52] argues that 
less pain medication is used by patients after laparoscopic procedures. In general, the 
adoption of a laparoscopic approach has been based on the rationale that there are 
fewer wound-related complications, less postoperative pain, and faster convalescence. 
[47, 52, 53] Nguyen goes on to argue that pulmonary function in an already 
vulnerable population. is less compromised in laparoscopically treated patients, since 
"the extent of depression of pulmonary function is related to the magnitude of 
operative ttawna. H [47] Only three randomized trials are known to compare 
laparoscopic versus open gastric bypass, the first was based on 51 patients by 
Westling and Gustavasson. in which they found no difference in postoperative pain, 
length of hospital stay or length of convalescence. [54] Looking at the National 
Inpatient Survey for 2001 , Livingston found that hospital costs were lowest with 
laparoscopic bariatric procedures (versus open), despite having greater 
equipment/procedural costs. Overall, laparoscopic Roux-Y gastric bypass was most 
cost effective when all factors were taken into account. It is worthwhile to point out 
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that although LRYGB had the lowest medical complication rate, it had the highest 
technical complication rate. [55] (Figures 10, 11) 
Operative/perioperative data following tHe,open 'and 
laparoscopic approaches 
Parameter LRYGBP Open RYGBP P-value 
operatiVe.~m. 285±5O 155<48 < 0.001 
(min) . 
EBl" (mL) " ... , 125<68 305±83 < 0.001 
ICU stay (days) 0 3 . . . . 
Hospital LOS " ' 3.5 < .6!l 4.8.1 .2 < 0.001 
(days) ':! . 
T'";~slusk>ri$ ", 
. . ,' '0 2 . 
-estimated bloOd, loSs. ValUes are mean ± SO [ 56] 
Figure 10. OptrativelPerioperative Data Following the Open and Laparoscopic Approaches. 
Cost of gastric bypass usirng the laparOScopic and 
open approach" 'c 
h 
LRYGBP Open RYGBP P-value 
,~ , 
Direct Cost '~.~ . 4180:1:382 3179.101 < 0.001 
, 
~~di~~t 1792 '26:3 2137 ±285 < 0.001 
.I~tal Co~ 6350< 75 7894,264 < 0.001 
• Cost = U.S. Dollars. Values are mean ± so [ 56] 
Figure II. Cost of Gastric Bypass Using the Open and Laparoscopic Approaches. 
History of Gastric Bypass 
An ideal operalion for control of obesity should limit ability to 
overeat and yet should allow normal nutrition. Subtotal gastric 
resection would satisfy these objectives but is too radical and 
irreversible. 
Gastric bypass is an operation exactly like Billroth n gastric 
resection except that nothing is removed. A 15 to 30 per cent 
fundic segment is anastomosed to the upper jejunum. The distal 
segment of stomach is closed and sutured to the surface of the 
fundic pouch. [30] 
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So wrote Edward E. Mason, M.D. PhD., FACS and Chikashi Ito, MD. in the first 
paper about gastric bypass for the treatment of morbid obesity. Although preceded 
by the introduction of malabsorpcive procedures in the 1950's, it wasn't until 1967 
that Mason and Ito first published their account of gastric bypass in a morbidly obese 
woman. In the late 1950·s. Mason, then a junior surgical resident at the University of 
:Minnesota performing antral exclusion on dogs as a model for ulcer production, 
noted that severe weight loss. a side effect of the procedure. could be safely 
accomplished and could prove beneficial to obese patients. The inaugural human 
subject was a 50-year old female who stood 4 feet 10 inches tall and weighed 208 
pounds (BMI = 43.5 kg/m2). Mason and Ito performed a gastric bypass, transecting 
the stomach horizontally (36] leaving 20 percent of the proximal gastric fundus 
anastomosed to the jejunum, 24 inches beyond the Ligament of Treitz. The 
gastroenterostomy was anterior to the colon and the distal closed segment of the 
stomach was sutured to the anterior surface of the fundic segment, [30] creating an 
upper gastric pouch between 100 mL and 150 mL with a stoma 12 mm in diameter. 
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[36] (Figure 12) It is important to point out that in this foundational operation, 
Mason and I to performed a loop and not a Roux limb bypass, as will be discussed 
below. The patient subsequently lost 60 pounds over 9 months. Early satiety and 
sweet intolerance, which appeared within two months of the procedure, were the 
patient's only complaints after surgery. 
Figure 12. Origi nal Mason and Ito Gastric Bypass with Gastric Transection and Loop 
Gastrojej un ostomy. 
Mason and Ito conclude their first paper by calling for the investigation of and 
caution against the widespread use of gastric bypass before sufficient testing of the 
procedure was completed. 
In 1977, Alden revised the gastric bypass procedure by stapling across the stomach 
horizontally, without dividing the stomach. He too used a loop gastroejunostomy. 
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[57] In that same year, Griffen published the bypass pxocedure with an alteration: the 
Roux-Y gastrojejunostomy instead of the loop. [58J (Figure 13) Henry and Jane 
Buchwald cite the advantages to the Roux-Y over the loop gastrojejunostomy as 
avoiding tension on the loop and preventing bile reflux back into the gastric pouch. 
[36J Randorruzed trials comparing the Roux-Y to the then standatd loop, 
demonstrated weight loss comparable to the levels reached by jejunoileal bypass, 
which until then had led to superior results. 
Further contributions to the gastric bypass procedure include: a vertically stapled 
stomach and a long-limb Roux-Y bypass for super-obese patients and for those with 
unsatisfactory results after conventional (short-limb) Roux-Y bypass. Long-limb 
gastric bypass has since been advocated as a primary procedure for super-obese 
patients. [59, 60J In 1994, Wittgrove, Clatk and Tremblay first reported the technique 
oflaparoscopic Roux-Y gastric bypass. [61J Higa, in 1999, suggested hand-sewing the 
gastrojejunostomy lapatoscopically as a means of preventing anastomotic leaks that 
could complicate laparoscopic gastric bypass. [36, 62J 
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Figure 13. Griffen Gastric Bypass: Horizontal Gastric Stapling with Roux-Y Gastrojejunostomy. 
Various incarnations of the gastric bypass are still in practice today based on the 
training, skill and preference of the surgeon. 
Significance of the Gastric Pouch Size 
By 1972, Mason and Ito had performed and subsequently published their series of24 
patients, aU treated with 90% gastric bypass. Reinhold ootes, however, that 30% of 
the series necessitated revisional procedures because the original pouch created ( ..... 150 
cc) was too large and led to inadequate results. [63] Mason himself agrees with this 
notion as is evident in his 1981 book, Surgery for Morbid Oberi!y, in which he 
consistently and adamantly stresses (no less than eight times) the need for a "small 
gastric pouch." [64] 
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Aftet Mason published a revision paper recommending a restricted pouch, 
subsequent papers echoed the sentiment, seerrililgly taking it as gospel and 
considering it a technical requirement for the procedure, without much reflection or 
testing. In his comparison of gastric and jejunoileal bypasses, Alden credits improved 
outcome on reduced pouch and gastroenterostomy sizes. [57] Early on in the 
practice of gastric bypass, surgeons routinely measured pouch volume 
intraoperatively. MacLean measured the pouch by using an esophageal tube. filling it 
with saline and occluding the outflow before stapling across the stomach. [65] 
Alder called for mandating intraoperative standards to assure reproducible pouch and 
stoma sizes. [66] Yet even as the bypass procedures evolved as described above, 
validation of pouch size seemed to be left off the list of variables to test with respect 
to gastric bypass. A literature review using MEDLlNE, PubMed and Cochrane 
Databases yielded only two papers specifically devoted to testing the notion that 
pouch size effected outcome after gastric bypass. The literature search did yield 
nwnerous articles outlining the best way to measure the pouch volume after gastric 
bypass. 
Curiously, the majority of articles raising the question of pouch volume and its 
corollary, pouch dilatation was more often (and &:equendy) discussed in the literature 
regarding gastroplasty and gastric banding procedures. Much attention is paid to the 
subject and although the consensus seems to fall in support of pouch size affecting 
outcome after gastroplasty.[67, 68] 
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Lundell, in his 1987 paper, ''Measurement of Pouch Volume and Stoma Diameter 
After Gasttoplasty," found a significant correlation between stoma diameter and 
weight reduction during the first six postoperative months, but found no correlation 
between pouch volume and weight loss. [67] Nevertheless, Lundell, too called for 
precise measurement of pouch volume and stoma diameter [after gasttoplasty] to 
evaluate long-term results of bariatric surgery after declaring "successful results in the 
short and long term have implied the establislunent of a small fundic pouch 
combined with a narrow and stable outlet." In 1981, Naslund published the results 
of a randomized prospective study of 57 patients that compared gastric bypass and 
gastroplasty, in which pouch and stoma sizes we.re included as variables of interest. 
In it, Naslund found that there was a correlation between pouch and stoma sizes and 
postoperative weight loss after gastroplasty, but not a similar correlation after gastric 
bypass. He ~tes, "In gastric bypass, the pouch size, at least if initially less than 50 
mL, does not seem to be of the same importance as in gastroplasty. Patients with 
larger pouches lost weight as much weight as those with smaller ones." He ascribes 
this difference in importance of pouch size to possible different mechanisms of 
weight loss between the two procedures: gastroplasty has an effect because of 
mechanical factors, which he thought was insufficient to explaill weight loss after 
gastric bypass. [69] In 1995, Naslund revisited the question of pouch volume 
affecting weight loss. this time posing the question with respect to vertical banded 
gasttoplasty. With intraoperative saline measurements, he looked at three pouch 
volumes: 20 mL, 30 mL and >40 mL, but was unable to show a difference in weight 
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loss between the three groups. [70J (Figure 14) While no definitive answer exists in 
the literature regarding an absolute upper limit to the size of the gastric pouch for 
gastric banding, it appears that pouch dilatation is accepted as a real and significant 
complication of gastric banding, one that may necessitate reoperation for band 
repositioning. [40, 71-73J Why then have pouch size and pouch dilatation not been 
similar conccrns after gastric bypass? 
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Figure 14. Weight Loss as a Function of Pouch Volume After Vertical Banded Gastroplasty. 
[67] 
Laparoscopic Gastric Bypass Surgery at Yale New Haven Hospital 
Patients are taken to the operating room, placed .in the supine position and prepped 
and draped in the standard surgical sterile fashion using the sequential ap plication of 
Hibiclens® (Regent Medical Americas, LLC., Norcross, GA) soap and DuraPrepTM 
(3WM, St. Paul, MN) solutions. Initial port access is in the patient's right upper 
abdomen at a site approximately three fingerbreadths below the xiphoid process, 
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slightly right of the midline. The site is anesthetized using a combination ( 0.5% 
marcaine and 1% lidocaine) anesthetic and a 12-millimeter skin incision is made. 
followed by Veress needle insertion. The abdomen is insuf£lated to achieve a 15 torr 
pneumoperitoneum with carbon dioxide. With adequate pneumoperitoneum 
achieved, the Veress needle is withdrawn and a 12-millimeter port is inserted into the 
abdomen. Using a 5-millimeter, thirty degree laparoscope, the abdomen is assessed 
before proceeding with direct visualization of subsequent port placements. 
The second port is placed approximated one fingerbreadth below the left costal 
margin in the anterior axillary line; the third is approximately three to four 
fingerbreadths below the eostal margin in the left midclaviewar line. Three additional 
ports are placed as well, as depicted in Figure 15. With the exception of the first port, 
all remaining ports are 5-mm.in diameter. 
3S 
Figure 15. Trocar Placement for LRYGB. 
Adapted from and Printed with penrussion; copyright 0 2001 PJ Quilici. All Rights reserved. [74] 
The left lateral segment of the liver is retracted anteriorly and cephalad, providing 
appropriate exposure of the gastroesophageal junction. The pars flaccida of the 
lesser omentum is divided. along with the gastrohepatic ligament, using an 
AutoSonix™ device. Using a 45-mm/3.5 nun staplet, the cardia is transected 
approximately 1-2 centimeters below the gastroesophageal junction. The rest of the 
stomach is transected with sequential firings of the stapler, yielding a proximal gastric 
pouch with an approximate 30 mL capacity. (Figures 16) 
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Next, attention is turned to the Ligament of Treitz. which is identified and the 
jejunum is followed approximately 25-30 em distally until its maximal mesenteric 
length is found. At this point, the 45 mm/3.5 rnm stapler is used to transect the 
Jejunum. The mesentery is div:ided using an EndoGlA™ stapler (Figure 17) and 
attention is paid to both limbs of the intestine, ensuring they are pink and viable after 
the division. 
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Next, the Roux (efferent) intestinal limb is maneuvered in an antecolic. antegastric 
fashion and positioned next to the previously traosected gastric pouch, and a 
posterior row of stay sutures are placed between the gastric pouch the jejunal limb 
using an EndoStitch device. Two parallel enterotomies are then created, one in the 
Raux limb of the jejunum and one in the gastric pouch, and a side-to-side 
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gastrojejunostomy is created by a single firing of the EndoGIATM 30mm/3.5 mm 
stapler. The stapler insertion site defect is then closed using a running #0 Surgidac ™ 
suture placed with the aid of an EndoSritch ™ device. The suture line is imbricated 
using three #0 Surgidac™ sutures in a horizontal mattress fashion. (Figure 18) 
Figure 18. Gastrojejunostomy, Posterior Row Sutures. 
Attention is next turned toward the creation of the jejunostomy. Using an umbilical 
tape. 60 em of Roux limb jejunum is measured and marked with a single 2-0 
Surgidac ™ suture. The previously transected proximal jejunum is then aligned in an 
antiperistaltic fashion with the point 60 em distal to the Raux limb. The two limbs of 
intestine are secured to onc another using two interrupted sutures placed in a 
seromuscular, antimesenteric fashion. Once secured. two parallel enterotomies are 
made using an Au!oSonix ™ device: one on the proximal jejunum and one on the 
distal Roux limb and then using a 45 mm/3.S nun stapler, a side-to-side anastomosis 
is created. (Figure 19) Three sutures are used to close the defect from the stapler site, 
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which are then elevated and the staple line defect is completely closed by firing the 45 
mm/3.5 mm stapler. (Figure 20) Peterson's space is subsequently closed using two 
interrupted sutures. 
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Figure 21 . Illustration of Completed Roux-Y Gastric Bypass. 
After inspection of the anastomosis, an endoscope is passed through the mouth, 
down the esophagus and through the gastrojejunal anas tomosis, to ensure the newly 
created anastomosis is intact, patent and not under tension. (Figure 22) 
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Figure 22. E",IO"cop';, 
The scope is then withdrawn to the level of the gastric pouch and an anastomotic 
leak test performed: the gastric pouch is insufflated, while simultaneously flooding 
the operative field with nonnal saline. (Figure 23) In the absence of bubbling, it can 
safely be assumed no leaks exist along the anastomotic suture lines and the 
endoscope is withdrawn. 
Figure 23. Anastomotic Leak Test. 
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A 19 French round Jackson-Pratt drain is inserted and placed next to the 
gastrojejunal anastomosis; The dtain is exteriorized through the left lateral most 
incision and secured with two interrupted 2-0 Nylon sutures. The liver retractor is 
closed and withdrawn from the right lateral most port under direct laparoscopic 
visualization. All of the other ports are then withdrawn and the abdomen desufflated 
of all carbon dioxide. The port sites are reinjected with combination anesthetic and 
the subcutaneous tissue and the 12-mm port is closed with Biosyn ™ suture in an 
interrupted suhcuticulru: fashion. All five of the remaining incisions are coapted with 
Inderemil™ surgical adhesive and dressed with Bancl-Aids™. 
The patient is extubated and transfe.tred to the Post-Anesthesia Care Unit when 
determined stable by the anesthesiologist. Patients are subsequently transferred to a 
surgical floor bed. where they are kept nothing per os overnight, and provided with a 
morphine sulfate pain pump for pain prophylaxis. 
An upper gastrointestinal (UGI) contrast evaluation of the gastric pouch is routinely 
perfonned on the first postoperative day. The pouch is maximally distended under 
continuous fluoroscopy and an anteroposterior (AP) film (Figure 24) and sequential 
spot images (Figure 25) are obtained once maximal distension is confirmed by the 
attending radiologist. Once anastomotic leaks are ruled out and gastric pouch 
emptying ensured by the swallow study, patients are advanced to a liquid gastric 
bypass diet and pain medications are changed to liquid oxycodooe and the Jackson 
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Figure 24. Typical Postoperative UGI Anteroposterior film. 
Pratt drain is removed. The patient is ambulated and discharged to home as soon as 
they feel ready. Follow-up is scheduled for 2-weeks, 2-months, 6-months, 12-




Between August 2002 and March 2005, 321 laparoscopic Roux-Y g<lstric bypasses 
were perfonned by two surgeons at Yale New Haven Hospital. All patients met the 
preoperative criteria of morbid obesity: 100% or 45.5 kg in excess of their ideal body 
weight. All underwent psychiatric evaluation, received printed material and were 
counseled regaxding operative risk and alternative procedures. Patient demographics, 
including age, gender, preoperative weight and BMI, excess body weight, operating 
time, length of hospital stay and complications were entered into a prospective, 
longitudinal Microsoft Excel database in accordance with HIPAA guidelines. [75J 
Patient weights, post-operative BMI, and %EWL wefe recorded on routine follow-up 
visits to the surgeons' office at 6, 12 and 24 months. All information was retrieved 
retrospectively. 
On the morning of post-operative day one, all LRYGB patients routinely undergo a 
Gastrografin® swallow study. An anteroposterior plain radiograph (AP film) is 
taken, which is followed by six and ten spot swallow images. Lateral radiographs 
were not included in the study due to equipment constraints imposed by patients' 
SIZe. Included on the AP film is a standard marker for calibration purposes. After 
completion, the swallow study films are scanned and digitized. and included in the 
patient's electronic medical record. 
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Because so few patients were eligible for 24 month follow-up at the time of writing, 
only 6 and 12 month data are included in this analysis. 
Calculating the Pouch Size 
Patient swallow studies were retrieved using Synapse, the Yale New Haven Hospital 
radiographic imaging software. Because films were variable, two different techniques 
were utilized to measure gastric pouch size; both methods assumed pouch depth 
remained constant between subjects. The first technique utilized an internal marker 
as a standard to calculate the vertebral height on the AP film. This height was then 
used in the subsequent spot film, ensuring the same vertebra was being measured, 
and the rnaxUnum length and width of the most distended pouch was measured and 
the area (in em') was detennined. (Figures 26 and 27) 
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Figure 26. Method A for Measuring Pouch Size: AP Film. 
Figure 27. Method A for Measuring Pouch Size: Spot Film. 
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Alternatively, if the gastric pouch appeared fully distended in the AP film, the internal 
market was used to measure the maximum length and width directly on the AP film, 
without need for measuring the spot films. (Figure 28) The technique used was a 
modification of the one described by Halverson [76] as well as by Anderson and 
Pedersen (77], but again, due to technical limitations, lateral films were not taken and 
therefore the volume, which otherwise would have been measured by calculating the 
length x width x 4/3n to obtain the volume. 
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Statistical Analysis 
Equations pertaining to weight are shown.in Figure 29. 
lLalculations 
, 
Body Mass Index - Weight (kilograms) , height' (meters) 
Ideal Body Weight' - Male 5' 3" 135 lbs, add 3 lbs per inch 
Female 5' 0" 119 lbs, add 3 lbs per inch 
Excess Weight - Operative Weight - Ideal Body Weight 
% Excess Weight Loss - [(Operative Weight - Follow-up Weight) / Operative 
Excess Weight] x 100 
Figure 29. Weight Equations. 
* mw based on Merropolitan Life Insurance Tables. [78] 
Linear and multiple regression analyses were perfonned using SPSS 13.0 (SPSS Inc., 
Chicago, ll.) to detennine the association between pouch size and excess weight loss 
at six and twelve months postoperatively. Adjustments were made for age, gender 
and preoperative BMI. Prior to analysis, all factors were examined with SPSS for 
accuracy of data entry, distribution and the assumptions of parametcical statistical 
analysis. Because the preoperative BMI and pouch size distributions were found to 
be positively skewed, the natutallog (In) was used to transfonn these factors in order 
to fulfill the normality assumption. 
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Analysis of variance was tested by subdividing pouch size and preoperative BMI into 
discreet gtoups to test the difference in means between pouch size, preoperative BMI 
and gender. Tukey and planned contrasts were utilized to explore the effect of pouch 
size on excess weight loss at six and twelve postoperative months. 
Minitab was used to generate all graphical data, which included analysis of %EWL 
and BM! as a function of pouch area, gender and age. Initial SPSS analysis examined 
all patients individually; Minitab analysis examined individual patients as well as 




Three hundred twenty one patients underwent surgery and were included in the initial 
analysis pool. Mean patient age was 41 yea" (range 17-64); 262 were female (81.5%) 
(Figure 30); mean age for men was older than for women. (Figures 31,32) Mean 
Percentage of Patients By Gender 
Figure 30. Percentage or Patients by Gender. 
preoperative BMI was 51.1 kg/m' (range, 36.1-89.9 kg/m'), whieh demonstrated a 
moderate positive skew. (Figure 33). Mean 6 month %EWL was 50.5% (range, 13.4-
85.5%) and mean 12 month %EWL was 62.5% (range 14.6-98.1). Mean poueh size 
was 63.9 em' (range, 8.6-248.0 em'), with a significant positive skew. (Figure 34) 
Patients between the ages of 30 and 50 represented the greatest number of patients 
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Sixty-nine patients were lost to follow-up at the six month mark, eight of whom 
subsequendy returned for their 12-month post-operative appointments. These 
52 
patients were included in the 12 month analysis, but not 111 the SIX month 
measuxement. One-hundred fifty-one patients did not keep their 12 month 
appointment, three of whom subseguently returned for their 24-month post-
operative appointments. Thirty-three patients were eligible for and had 24 month 
post-operative follow-up weights. Two-hundred sixteen Gastrografin® swallow 
studies were available for review. 








Panel variable: Gender; 1= Males, 2= Females 
Figure 32. Patient Mean Ages by Gender. 
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Figure 35. Percentage of Patients by Age Decade. 
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Multiple linear regression analysis was used [Q examine the relationship between age, 
gender, p.reoperative BMI. pouch size and excess weight loss at 6 and 12 months 
postoperatively. A statistically significant negative correlation between pouch size 
and percent excess weight loss (%EWL) was found at the sixth post-operative month 
(~ = -.241, p<O.Ol) as well as at the twelfth post-operative month (~ = -.302, p<0.02) 
(Figures 37, 38). with adjustments made for age, gender and preoperative BMI 
(unadjusted 6-month ~ = -0.39, p<O.OOl and 12-month ~ = -.383, p<O.OOl). Linear 
regression analysis confinned rate of change in %EWL as a function of pouch size 
remained relatively constant from the time of procedure through month twelve. 
(Figure 39) 
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Figure 37. 6-Montb %EWL as a Function 01 Pouch Area. 
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Figure 38. 12·Month %EWL as 8 F unction of Pouch Area. 
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There was a Statistically significant positive correlation between male gender and 
pouch size r = .144. p<O.04 (Figure 40) after adjustments were made for age and 
preoperative BMl (unadjusted r = .168, p<0.02). With adjustment for age and 
gender, there was a statistically significant positive correlation between preoperative 
BMI and pouch size (adjusted r = .197, p<0.04, unadjusted r = .192, p<O.OI). 
(Figure 41) No correlation was found between pouch size and age when adjustments 
were made for gender and preoperative BMI ~ = .083, p=.23. 
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Figure 40. Mean Pouch Size by Gender. 
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Figure 41. Preoperative BMlln Correlation with Pouch Size. 
To determine analysis of variance, patients were grouped into five categories 
according to their pouch size and weight loss at 6 and 12 months post-operatively 
was evaluated in more detail. Group means of %EWL at 6 and 12 months are shown 
in Figure 42. Tukey and planned contrast analysis revealed statistically significant 
group mean differences in %EWL at 6 and 12 months. (Figure 43) 
Group>! 
. 
6 montli . 12 month' . , 
.;j . , . ~.1." . ,%ElNL mean, n %EWL mean, n . 
Group 1 (<30 Gm2) 54.B, n=36 63.6, n=15 
Group 2 (30-80 cm2) 55.0, n=53 69.3, nz:37 
Group:3 (80-90 an2) 48.3, n .uK) 6O.B, n=20 
Group 4 (90..1~ Q112) 45.4 n::2J 53.0, n=11 
Group 5 (>120 an2) 39.9, ""'18 -47.6, n:16 
Figure 42. Group Means by POlich Size. 
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Figure 43. Com pa rison orGroup Means With Statistical Significance . 
• P<' 0.05 
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To tease out further correlations and analysis of variance. patients were grouped again 
based on their preoperative BMI. Three different groups corresponding to low, 
intermediate and high BMI were evaluated against pouch size using analysis of 
variance F(2,213) = 4.654, p=.O. l1 and post hoc planned conttasts. Group A: <50 
kg/m', Group B: 50-60 kg/ m' and Group C: >60 kg/ m'. ANaVA resting 
demonstrated: Group A: mean 56.1, n= 120; Group B: mean 65, n=65; and Group C: 
mean 73.7, 0=31. (Figure 44) A statistically significant cliffe.rence was found between 
Group A and Groups B and C (p<0.05). 
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These data demonstrate a significant inverse correlation between the size of the 
gastric pouch constructed during LRYGB: patients with smaller pouch sizes lost 
significantly more weight at 6 and 12 months postoperatively. Male gender and 
preoperative BMI were factors that influenced the construction of larger gastric 
pouches. 
Summarizing the results of the contrasts, we found that with the exemption of a few 
pair-wise comparisons. the weight loss was significantly greater for the groups with 
smaller pouch sizes. 
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Preview of Preliminary Results 
At the time of writing, significant data was only available for 6 and 12 month follow-
up. However, in anticipation of furure analysis, review of preliminary data from the 
24 month yielded interesting findings. Figure 45 demonstrates a stepwise analysis of 
%EWL as a function of age decade. 
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. Figure 45. %EWL versus Age Decade. 
While patients in their sixties initially lose a percentage of their excess weight quickly 
in the first six months, their rate of weight loss quickly drops off and they ultimately 
lose less weight than younger patients by the 24th month. Percent excess weight loss 
parallels patient ages except for patients in their thirties, who lose weight more 
quickly than older patients and those in their twenties. There was insufficient data at 
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the time of writing to confirm whether the slope of weight loss for patients younger 
than 20 will remain the same. Figure 46 illustrates the corollary, decreasing BMI 
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Future analyses will continue to look at time points beyond two postoperative years 
and aim to include more complete patient follow-up. 
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Discussion 
Obesity is on the rise. It has become a global problem that now disproportionately 
affects minorities and the underprivileged. [3, 37] Surgery has proven the only 
effective therapy and Roux-Y gastric bypass. first devdoped in 1966, has become the 
most frequently perfonned bariatric procedure in the U.S. Several components play 
key roles in achieving optimal weight loss after gastric bypass surgery and their 
identification is the most important endeavor in the latest research aiming to increase 
excess weight loss. Patient factors, including compliance with proper diet and 
exercise, cannot be over emphasized. Those technical considerations that contribute 
to outcome success must also be analyzed and tested systematically. Of these, size of 
the surgically created gastric pouch and the caliber of the gastrojejunostomy stoma 
have been debated fo.r more than twenty years but without systematic methodological 
testing. There is a lack of substantiating literarure regarding the relationship between 
pouch size and excess weight loss after Roux-Y gastric bypass surgery and the exact 
narure of the association between pouch size and EWL remains elusive. 
Despite numerous consensus panels convened to define surgical technique, [79J there 
is no standard recommendation or guideline concerning intraoperative measurement 
of the gastric pouch. Some surgeons have historically measured the volume of the 
pouch while performing the procedure, (76] a practice which persists in some centers. 
To date, the majority of literature describing intraoperative measurements and the 
rationale for doing so refers to gastric banding procedures [70. 80-821. not to gastric 
64 
bypass surgery. The literature that does exist regarding gastric bypass is lacking in 
two regards. FiIstiy, the literature predominantly predates current laparoscopic 
practice and secondly, most authors measure pouch size months and sometimes years 
after the surgery was perfonned. In 1996, Flanagan published his method of 
measuring functional pouch volume by asking patients to ingest cottage cheese and 
report their level of satiety before return visits anywhere from 3 months to 2 years 
postoperatively. He then assumed the amount of cottage cheese consumed 
correlated with pouch volume and found no association between pouch size and 
weight loss. Besides his unconventional method for measuring pouch size, his study, 
by virtue of measuring the pouch long after the procedure, very likely introduces 
confounding factors, such as passive stretch pouch enlargement from overeating and 
pouch hyperplasia, which can occur after the surgery. [83] Because Flanagan 
measured the pouch indirectly and so long after surgery, we believe his findings do 
not contradict our own association between pouch size and excess weight loss. 
Flanagan's report is only one example of several that demonstrates the unreliability of 
measuring pouch size after a variable amount of time and therefore precludes the 
ability to make reliable inferences about intraoperative pouch size and its correlation 
to excess weight loss. 
Precise measurement of the gastric pouch is equally important and challenging. 
Literature of the past decades describes many different ways about how to measure 
gastric pouch size. [76, 83, 84] In 1977, Alder [66] advocated the precise 
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intraoperative measurement of pouch size with injected saline through a nasogastric 
tube prior to stapling the stomach. [76] Other techniques used to measure pouch size 
were innovative creations like Fogarty catheters attached to a nasogas tric tube inflated 
with fluid. [85J And although the efficacy and efficiency of these former methods ate 
questionable, the early recommendation to measure pouch size precisely is an 
important element of surgical practice that our present study wishes to expand upon 
and endorse in order to draw more reliable inferences about the correlation between 
pouch size and weight loss. In light of the controversy concerning this relationship, 
there are not enough efficient methods available to measure pouch size 
intraoperatively or shor tly thereafter (one exemption is the inflatable balloon used in 
gastric banding surgery). Most bariatric surgeons today therefore estimate the pouch 
size from a specific distance from the gastroesophageal junction ot by ttansecting the 
stomach between the second and third right gastric arterial cascades. 
The measurement of gastric pouch size .postoperatively has also proved technically 
difficult. Radiographically, attempting to measure a three-dimensional pouch volume 
from a two-dimensional filled-contrast pouch image is mathematically challenging 
and only allows for an estimate of volume by measuring maximal pouch height and 
length; this is therefore a limitation in om current study design. The National 
Institutes of Health is cutrently testing imaging software that counts pixels) so in the 
near futw:e it may be possible to measure pouch volume by contrast intensity. 
However, in the absence of any current mote accurate way of feasibly measuring 
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pouch volume that we have come across, we assume that our swallow evaluation is 
sufficiently accurate to give an acceptable opinion about the relative pouch size one 
day after surgery. Similar conclusions were drawn by Kuzmak measuring the pouch 
size with a Gastrografin® swallow evaluation. [80] Furthermore, we believe the 
technique acceptable as Forsell demonstrated that pouch volume measured by 
swallow evaluation and MRl fall into the same volume category. [86] One other 
consideration is that ow: measurement might underestimate the actual pouch size due 
to mucosal edema in the pouch. However, the assumption was made that all pouches 
sustained similar overall trawna and mucosal edema was therefore comparable 
between pouches. Adclitionally, postoperative anastomotic edema might result in a 
tighter stoma which would delay stomal contrast emptying, thereby stretching the 
pouch and portraying a larger pouch. The diameter of the stoma is another oft 
discussed factor in weight loss after restrictive procedures, (67, 77. 85, 87, 88] but we 
were unable to include it in our analysis because of an inability to adequately measure 
the stoma during swallow evaluation. Nevertheless, we heed the early 
recommendations and acknowledge that a small stoma diameter is an important 
factor in restricting solid food from passing too quicldy and easily into the Roux limb, 
and contributing to passive stretching of the pouch, which is responsible for inducing 
the feeling of satiety, limiting caloric intake and ultimately causing weight loss. To this 
end, the surgeons in this study aim for a stoma size of approximately 12 to 15 
millimeters. 
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While recognizing that the precise and timely intraoperative measurement of gastric 
pouch size is challenging with current in surgical methods. the problems emerging 
from postoperative pouch measurements (such as the estimation of a wee-
dimensional pouch from a two-dimensional contrast area), and the possibility of 
radiograpWcally underestimating pouch size from mucosal edema. we nevertheless 
are convinced that precise measurement of the pouch size intraoperatively or shortly 
thereafter is indispensable for any study aiming to make a valid claim about the 
relationship between pouch size and resultant weight loss. With acknowledgement of 
all the aforementioned limitations, our study still confi.tmed that there is a significant 
inverse relationship between pouch size and excess weight loss. 
After establishing the negative correlation between pouch size and excess weight loss, 
further analysis of those factors that could possibly influence results: age, gender and 
preoperative BMI, were evaluated. To the best of our knowledge, no existing 
literature concerning the relationship between pouch size, weight loss and gastric 
bypass evaluates these factors. No significant correlation between age and gastric 
pouch size was found, but interestingly, we did find that male gender was significantly 
correlated with a bigger pouch size and subsequently with a lower per cent excess 
weight loss. We posit one explanation for thls finding may be that males have more 
intraabdominal fat, which translates to a more challenging dissection and a more 
difficult operation overall, resulting in the construction of a bigger pouch. 
Additionally, we found a statistically significant positive correlation between 
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preoperative BMI and pouch size, possibly indicating that increased BM! may 
similarly lead to a more challenging operation, which again results in an increased 
pouch size. 
Analyzing these potential confounders. we identified higher preoperative BMI and 
male gender as risk factors for larger pouches and decreased subsequent overall 
weight loss. These findings need to be addressed conscientiously in the hope that 
acknowledgement will guide practice toward the creation of a smaller pouch, 
especially in male patients and those with increased preoperative BML 
In conclusion, our study clearly demonstrates that when the importance of precise 
pouch measurement is acknowledged and when the pouch size is measured within a 
sho.rt period of time after surgery, size does in fact matter: there is a significant 
inverse relationship between the size of the surgically constructed pouch and excess 
weight loss following laparoscopic Roux-Y gastric bypass. 
Until such a time that our limitations are addressed and firm recommendations ate 
made .regarding intraoperative pouch measurements, we must continue to heed the 
guiding principles by Edward E. Mason, the founding father of gastric bypass: 
Operative procedure must be standardized and the technique 
carefully documented after each operation. Data must be 
col/ected in a standardized fashion and analyzed. We must find 
out the life-long results so that we can inform patients as to the 
consequence of their choice of operation. This review of past 
experience and exchange of in/ormation is the time-honored 
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